Treatment for Cancer may be Effective Against Heart Disease

Peptide receptor radionuclide therapy, an established therapy for cancer patients could help reduce levels on inflammation in those suffering from atherosclerotic plaque.

"Our results should act as a stimulus for further exploration of radionuclide based interventions in atherosclerosis. Ultimately such therapies might be used to lower the degree of inflammation in atherosclerosis which has the potential to reduce the occurrence of heart attacks," said Imke Schatka, the first author of the study from the Department of Nuclear Medicine at Hannover Medical School, Germany.

Anti-Cancer Drug Restores Normal Cell Growth
An experimental anti-cancer drug has shown effectiveness in treating a resistant type of lymphoma, according to a new report. Researchers say the

PRRT is a technique currently used to treat patients with metastatic neuroendocrine tumours (NETS), a diverse group of malignancies deriving from the neuroendocrine cell system (the most frequent locations being pancreas, small intestine and lung).

The discovery of over expression of somatostatin receptors (SSTR) on NET tumours first opened the way for development of radiolabelled somatostatin analogs to image tumours during PET/CT scans. DOTATATE is a somatostatin receptor (SSTR) ligand targeting SSTR-2, a receptor known to be expressed on 70% of NET tumours. Once tumours have been visualized, it is possible to target therapy by attaching the beta-emitter ¹⁷⁷ Lutetium (¹⁷⁷Lu) to the ligand.

Active inflammation has been widely implicated in the initiation, progression and disruption of vulnerable plaques, and consequently offers an emerging target for the imaging and treatment of atherosclerosis. "Since SSTR-2 receptors are also expressed on macrophages we speculated that DOTATATE-PET/CT might be used to detect vulnerable plaques and that a PRRT procedure could reduce inflammation in the arterial wall," explained Schatka.

No Increased Risk of Certain Cancers from Electromagnetic Fields Among Energy Workers
Electromagnetic fields do not pose a health hazard to workers in the electrical energy supply industry, suggests a large study of 28,000 people

For the current study, 11 patients (from a group of 165 undergoing PRRT for NET tumours) were retrospectively identified because they met the criteria of only receiving the beta emitter¹⁷⁷Lu treatment after undergoing two consecutive scans, with a third scan following treatment.

For each of the three scans, vessel wall uptake of the DOTATATE ligand was measured in six arterial segments of PET images (carotid, aortic arch, ascending, descending, abdominal aorta, and iliac arteries) and then the overall vessel uptake was determined for each individual patient.

Death Risk Higher in Obese Women with Colon Cancer
In women with colon cancer that has advanced beyond the early stage, obesity is associated with a poorer long-term outcome, according to a recent

Results showed that for the first scan the overall vessel uptake of the ligand correlated with the age of the patient (P<0.01), the number of calcified plaques (P<0.001) and furthermore was higher in subjects with hypercholesterolemia (p=0.04). No significant differences in overall vessel uptakes were found between scans 1 and 2, confirming reproducibility in the absence of treatment.

However, when treatment with the beta-emitter ¹⁷⁷ Lu-DOTATATE was delivered following scan 2, scan 3 showed significant reductions in the overall vessel uptake of the ligand when compared with both scan 1 (p=0.001) and scan 2 (p=0.004).

Quality of life after cancer
According to American researchers many cancer survivors report a good quality of life, despite facing physical and psychological struggle. But

"Uptake of the ligand can be considered to be a measure of the quantity of SSTR receptors, which in turn is likely to correlate with the number of activated macrophages and the extent of the inflammatory process," explained Schatka. "Our results suggest that treatment has had a beneficial effect in reducing inflammation."

The next step, said Schatka, would be to get histological proof that reductions in inflammation really had been imaged with DOTATATE-PET/CT by looking at carotid artery samples removed from patients during routine surgery.

Source-Eurekalert